Medical Oncology in Henderson, NV
3 verified medical oncology doctors in Henderson.
Medical oncologists diagnose and treat cancer, coordinating chemotherapy and other systemic cancer therapies.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Nevada State Board of Medical Examiners
Dr. Ghulam Kashef, MD
Medical Oncology
CMS Open Payments· $2,161 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,161
Total received
120
Transactions
30
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 65th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Ghulam Kashef do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Claire Hiles, MD
Medical Oncology
CMS Open Payments· $80.89 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$80.89
Total received
3
Transactions
3
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total is on the lower end — around the 46th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Claire Hiles do not imply any wrongdoing. Many are meals, education, or research support.
Dr. David Kotlyar, MD
Medical Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.